INSULIN PUMP WITH CONVENIENCE FEATURES

• US 20090177154A1
• Filed: 01/08/2008
• Published: 07/09/2009
• Est. Priority Date: 01/08/2008
• Status: Abandoned Application

• Current Assignee: Smiths Medical ASD, Inc. (Smiths Group International Holdings Ltd.)
• Original Assignee: Smiths Medical ASD, Inc. (Smiths Group International Holdings Ltd.)
• Inventors: Blomquist, Michael
• Application Number:
  US11/970,691
• Publication Number:
  US 20090177154A1
• Time in Patent Office: Days
• US Class Current: 604/131
• CPC Class Codes: A61M 2005/14208 with a programmable infusion control system, characterised by the infusion program
• CPC Class Codes: A61M 2205/502 User interfaces, e.g. screens or keyboards
• CPC Class Codes: A61M 5/14244 adapted to be carried by the patient, e.g. portable on the body
• CPC Class Codes: A61M 5/1723 using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00
• CPC Class Codes: A61M 5/427 Locating point where body is to be pierced, e.g. vein location means using ultrasonic waves, injection site templates
• CPC Class Codes: G16H 20/17 delivered via infusion or injection
• CPC Class Codes: G16H 40/63 for local operation

Abstract

This document discusses, among other things, an apparatus comprising a pump configured to deliver insulin, a user interface including a display, and a controller communicatively coupled to the pump and the user interface. The controller includes a site display module configured to display a next suggested location of the body for the user to use in treating diabetes from a series of suggested body locations.

Claims

1. An apparatus comprising:

a pump configured to deliver insulin;

a user interface including a display; and

a controller communicatively coupled to the pump and the user interface, wherein the controller includes a site display module configured to display a next suggested location of the body for the user to use in treating diabetes from a series of suggested body locations.

2. The apparatus of claim 1, wherein the site display module is configured to display a next suggested infusion site for the user from a series of suggested infusion sites.

3. The apparatus of claim 2, wherein the site display module is configured to display the next suggested infusion site for the user by rotating through a series of body infusion site locations for display.

4. The apparatus of claim 3, wherein the series of body locations is a subset of possible body locations selectable by a user.

5. The apparatus of claim 2, wherein the site display module is configured to display the next suggested infusion site when an insulin cartridge is connected to the pump.

6. The apparatus of claim 1, wherein the site display module is configured to display a next suggested location of a next blood glucose test site for the user from a series of blood glucose test sites.

7. The apparatus of claim 6, wherein the site display module is configured to select the next suggested blood glucose test site for display by rotating through a series of body test site locations for display.

8. The apparatus of claim 6, including a blood glucose monitor, communicatively coupled to the controller, and wherein the site display module is configured to display the next suggested location of a next blood glucose test site when a blood glucose test strip is inserted into the insulin pump device.

9. The apparatus of claim 6, wherein the controller is configured to execute a plurality of features selectable via a menu displayed on the user interface, and wherein the site display module is configured to display the next suggested location of a next blood glucose test site when a menu choice is selected that requires a blood glucose measurement.

10. The apparatus of claim 1, wherein the site display module is configured to display a graphic of the suggested body location.

11. The apparatus of claim 1, wherein the site display module is configured to display a code indicating the suggested body location.

12. The apparatus of claim 1, wherein the site display module is configured to rotate the next suggested site only through locations previously indicated by the user as desirable for treating diabetes.

13. A method comprising:

providing insulin therapy to a user of a device that includes an insulin pump; and

displaying, with the device, a next suggested location of the body for the user to use in treating diabetes from a series of suggested body locations.

14. The method of claim 13, wherein displaying a next suggested location of the body includes displaying a suggested location of a next infusion site for the user.

15. The method of claim 14, wherein displaying the suggested location of the next infusion site includes displaying the suggested location of the next infusion site when a cartridge is loaded into the insulin pump device.

16. The method of claim 14, wherein displaying the suggested location of the next infusion site includes selecting the suggested site for display by rotating through a series of body infusion site locations.

17. The method of claim 16, wherein rotating through the series of body infusion site locations includes rotating through a subset of possible body locations selected by the user.

18. The method of claim 13, wherein displaying a next suggested location of the body includes displaying a suggested location of a next blood glucose test site for the user.

19. The method of claim 18, wherein displaying the suggested location of the next blood glucose test site includes displaying the location of the next blood glucose test site when a blood glucose test strip is inserted into the insulin pump device.

20. The method of claim 18, wherein displaying the suggested location of the next blood glucose test site includes displaying the suggested location of the next blood glucose test site when a menu choice, displayed on the insulin pump device, is selected that requires a blood glucose measurement.

21. The method of claim 18, wherein displaying the suggested location of the next blood glucose test site includes selecting the suggested site for display by rotating through a series of body test site locations.

22. The method of claim 13, wherein displaying a next suggested location of the body includes displaying a graphic of the body location.

23. The method of claim 13, wherein displaying a next suggested location of the body includes displaying a code indicating the body location.

24. The method of claim 13, wherein displaying a next suggested location of the body includes rotating the suggested site through only those locations indicated as desirable by the user for treating diabetes.

25. An apparatus comprising:

a pump configured to deliver insulin;

a user interface including a display; and

a controller communicatively coupled to the pump and the user interface, wherein the controller includes a vision test module configured to execute a test to monitor a central visual field of a user.

26. The apparatus of claim 25, wherein the vision test module is configured to display an Amsler Grid on the display.

27. The apparatus of claim 26, wherein the vision test module is configured to display instructions for using the Amsler Grid.

28. The apparatus of claim 26, including a memory communicatively coupled to the controller, wherein the controller is configured to:

receive a coordinate of the Amsler Grid via the user interface;

store the grid coordinate in the memory as indicating a location of visual distortion; and

display any grid coordinates, stored over a period of time, which indicate visual distortion.

29. The apparatus of claim 25, wherein the vision test module is configured to periodically display a prompt to the user to execute the test to monitor a central visual field of the user.

30. The apparatus of claim 29, wherein the vision test module is configured to display the prompt in a time relationship to a bolus delivered using the insulin pump device.

31. The apparatus of claim 29, wherein the vision test module is configured to display the prompt in a time relationship to receiving a blood glucose measurement into the insulin pump device.

32. The apparatus of claim 29, wherein the vision test module is configured to display the prompt in a time relationship to when an insulin cartridge is changed on the insulin pump device.

33. The apparatus of claim 29, including a memory communicatively coupled to the controller, wherein the vision test module is configured to display the prompt according to a test schedule stored in the memory.

34. A method comprising:

providing insulin therapy to a user via a device that includes an insulin pump; and

executing, with the insulin pump device, a test to monitor a central visual field of a user.

35. The method of claim 34, wherein displaying the test to monitor the central visual field includes displaying an Amsler Grid on the insulin pump device.

36. The method of claim 35, including displaying, on the insulin pump device, instructions for using the Amsler Grid.

37. The method of claim 35, including:

receiving a coordinate of the Amsler Grid into the insulin pump device;

storing the grid coordinate in the device as indicating a location of visual distortion; and

generating a report using the insulin pump device, wherein the report includes any grid coordinates that indicate visual distortion.

38. The method of claim 37, wherein generating a report using the insulin pump device includes displaying the report using the insulin pump device.

39. The method of claim 37, wherein generating a report includes communicating the grid coordinates from the insulin pump device to a second separate device.

40. The method of claim 34, including periodically displaying a prompt to the user to execute the test to monitor the central visual field.

41. The method of claim 40, wherein periodically displaying a prompt includes periodically displaying a prompt to the user to execute the test in a time relationship to a bolus delivered by the insulin pump device.

42. The method of claim 40, wherein periodically displaying a prompt includes periodically displaying a prompt to the user to execute the test in a time relationship to receiving a blood glucose measurement into the insulin pump device.

43. The method of claim 40, wherein periodically displaying a prompt includes periodically displaying a prompt to the user to execute the test in a time relationship to changing an insulin cartridge on the insulin pump device.

44. The method of claim 40, wherein periodically displaying a prompt includes periodically displaying a prompt to the user to execute the test according to a test schedule stored in the insulin pump device.

45. An apparatus comprising:

a pump configured to deliver insulin;

a user interface including a display; and

a controller communicatively coupled to the pump and the user interface, wherein the controller includes an insulin calculation module configured to;

receive a desired time for changing an insulin cartridge via the user interface;

calculate an amount of insulin to be used by an insulin pump device user by the desired change time; and

display the amount of insulin to be placed in the cartridge on the display.

46. The apparatus of claim 45, wherein the insulin calculation module is configured to:

calculate a projected time the insulin cartridge will empty; and

display the projected time on the user interface of the device.

47. The apparatus of claim 46, wherein the insulin calculation module is configured to calculate the projected time in response to a prompt received via the user interface.

48. The apparatus of claim 45, wherein the insulin calculation module is configured to:

receive a prompt to initiate a delivery of a bolus of insulin;

calculate an amount of insulin in the bolus and compare the amount to an amount of insulin remaining in the cartridge; and

display a warning if the delivery of the insulin bolus would require a change of the insulin cartridge outside of the desired time.

49. A method including:

receiving information into a device that includes an insulin pump, the information including a desired time of an insulin cartridge change;

calculating a projected amount of insulin to be used by an insulin pump device user from about the time the information is entered until the desired change time; and

displaying, on a display of the insulin pump device, the amount of insulin to be placed in a cartridge.

50. The method of claim 49 including:

calculating a projected time the insulin cartridge will empty; and

displaying the time on the user interface of the device.

51. The method of claim 50, wherein calculating a projected time the insulin cartridge will empty includes calculating the projected time in response to a prompt received at a user interface of the insulin pump device.

52. The method of claim 49 including:

receiving a prompt to initiate a delivery of a bolus of insulin;

calculating an amount of insulin in the bolus; and

displaying a warning if the delivery of the insulin bolus would require a change of the insulin cartridge outside of the desired time.